Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -111.51% is 35% above its 5-year average of -170.59%, near the high end of its 5-year range (-601.59%–-38.75%).
As of the fiscal period ended Tuesday, June 30, 2026. 19.22% above its 12-month average of -138.05%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -111.51%.
RETURN ON EQUITY (ROE)
-111.51%
RETURN ON EQUITY (ROE) AVG TTM
-138.05%
RETURN ON EQUITY (ROE) AVG 3Y
-305.40%
RETURN ON EQUITY (ROE) AVG 5Y
-170.59%
RETURN ON EQUITY (ROE) AVG 10Y
-198.12%
RETURN ON EQUITY (ROE) AVG 15Y
N/A
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
+19.22%
CURRENT VS 3Y AVG
+63.49%
CURRENT VS 5Y AVG
+34.63%
CURRENT VS 10Y AVG
+43.71%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-37.16%
median of 398 covered companies
CURRENT VS SECTOR MEDIAN
-200.09%
vs the sector median at left
Genprex, Inc.
Market Cap
$1.37M
Return on Equity (ROE)
-111.51%
TTM Avg
-138.05%
3Y Avg
-305.40%
5Y Avg
-170.59%
Market Cap
$1.36M
Return on Equity (ROE)
-253.57%
TTM Avg
334.28%
3Y Avg
134.39%
5Y Avg
95.16%
Market Cap
$1.49M
Return on Equity (ROE)
-80.57%
TTM Avg
-96.07%
3Y Avg
-115.92%
5Y Avg
51.19%
Market Cap
$1.54M
Return on Equity (ROE)
-450.54%
TTM Avg
292.29%
3Y Avg
55.45%
5Y Avg
24.80%
Market Cap
$1.17M
Return on Equity (ROE)
N/A
TTM Avg
558.67%
3Y Avg
54.46%
5Y Avg
-8.27%
Market Cap
$1.14M
Return on Equity (ROE)
-11.85%
TTM Avg
-6.20%
3Y Avg
47.36%
5Y Avg
47.36%
Market Cap
$1.11M
Return on Equity (ROE)
-57.87%
TTM Avg
-222.45%
3Y Avg
-164.72%
5Y Avg
-135.78%
Market Cap
$1.02M
Return on Equity (ROE)
-93.97%
TTM Avg
234.49%
3Y Avg
123.23%
5Y Avg
1171.22%
Market Cap
$888387.00
Return on Equity (ROE)
-334.41%
TTM Avg
-290.71%
3Y Avg
-280.75%
5Y Avg
-198.19%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Genprex, Inc. (GNPX) | $1.37M | -111.51% | -138.05% | -305.40% | -170.59% |
| Artelo Biosciences, Inc. (ARTL)vs › | $1.36M | -253.57% | 334.28% | 134.39% | 95.16% |
| PMGC Holdings Inc. (ELAB)vs › | $1.49M | -80.57% | -96.07% | -115.92% | 51.19% |
| Curis, Inc. (CRIS)vs › | $1.54M | -450.54% | 292.29% | 55.45% | 24.80% |
| IM Cannabis Corp. (IMCC)vs › | $1.17M | N/A | 558.67% | 54.46% | -8.27% |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.14M | -11.85% | -6.20% | 47.36% | 47.36% |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | -57.87% | -222.45% | -164.72% | -135.78% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -93.97% | 234.49% | 123.23% | 1171.22% |
| Decoy Therapeutics Inc. (DCOY)vs › | $888387.00 | -334.41% | -290.71% | -280.75% | -198.19% |
| GlucoTrack, Inc. (GCTK)vs › | $885939.00 | N/A | -255.88% | -273.58% | -200.54% |
ROE
-111.5%
ROA
-96.3%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -111.51% |
| 2026-03-31 | -98.79% |
| 2025-12-31 | -203.83% |
| 2025-03-31 | -493.99% |
| 2024-06-30 | -601.59% |
| 2024-03-31 | -315.49% |
| 2023-12-31 | -416.11% |
| 2023-09-30 | -257.59% |
| 2023-06-30 | -249.70% |
| 2023-03-31 | -150.80% |
| 2022-12-31 | -107.67% |
| 2022-09-30 | -83.30% |
| 2022-06-30 | -62.31% |
| 2022-03-31 | -49.74% |
| 2021-12-31 | -47.47% |
| 2021-09-30 | -42.38% |
| 2021-06-30 | -38.75% |
| 2021-03-31 | -37.42% |
| 2020-12-31 | -58.04% |
| 2020-09-30 | -65.89% |
| 2020-06-30 | -60.14% |
| 2020-03-31 | -58.73% |
| 2019-12-31 | -352.39% |
| 2019-09-30 | -330.23% |
| 2019-06-30 | -215.42% |
| 2019-03-31 | -190.98% |
| 2018-12-31 | -139.31% |
| 2018-09-30 | -91.64% |
| 2018-06-30 | -64.63% |
| 2017-12-31 | -773.30% |
| 2017-09-30 | -418.42% |
| 2017-06-30 | -457.53% |
| 2017-03-31 | -411.92% |
| 2016-12-31 | -254.31% |
